Gene: ZNF596
Official Full Name: zinc finger protein 596provided by HGNC
Gene Summary: Predicted to enable DNA-binding transcription factor activity, RNA polymerase II-specific and RNA polymerase II transcription regulatory region sequence-specific DNA binding activity. Predicted to be involved in regulation of transcription by RNA polymerase II. Predicted to be active in nucleus. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO12131 | ZNF596 Knockout cell line (HeLa) | Human | ZNF596 | 1:3~1:6 | Negative | Online Inquiry |
KO12132 | ZNF596 Knockout cell line (HCT 116) | Human | ZNF596 | 1:2~1:4 | Negative | Online Inquiry |
KO12133 | ZNF596 Knockout cell line (HEK293) | Human | ZNF596 | 1:3~1:6 | Negative | Online Inquiry |
ZNF596 Gene Knockout Cell Lines represent a pioneering advancement in the field of genetic research, specifically designed to facilitate in-depth studies of the ZNF596 gene's function and its associated biological pathways. These cell lines are engineered using CRISPR-Cas9 technology to create a precise knockout of the ZNF596 gene, allowing researchers to explore the gene's role in cellular processes and disease mechanisms without confounding variables.
The primary function of these knockout cell lines is to enable a clearer understanding of gene function through comparative studies. By contrasting the knockout cells with their wild-type counterparts, researchers can investigate the phenotypic consequences of ZNF596 loss, including effects on cell proliferation, differentiation, and response to stressors. This is crucial for elucidating the involvement of ZNF596 in complex pathways such as transcription regulation and cell cycle progression.
From a scientific perspective, ZNF596 is implicated in a variety of clinical conditions, making these knockout cell lines invaluable for translational research. They provide a relevant model for studying human diseases, including cancer, neurodegenerative disorders, and metabolic syndromes, thus paving the way for potential therapeutic strategies targeting ZNF596-associated pathways.
What distinguishes our ZNF596 Gene Knockout Cell Lines from alternatives on the market is their high specificity and reliability, minimized off-target effects, and reproducibility in experimental outcomes. These cell lines are validated for optimal performance, ensuring that researchers can attain high-quality data in their experiments. Moreover, they are readily accessible and easily integrable into existing workflows, providing a seamless addition to both basic and applied research environments.
For researchers and clinicians striving to unravel the complexities of gene function and develop innovative therapeutic approaches, the ZNF596 Gene Knockout Cell Lines offer a key resource that enhances experimental design and accelerates discovery. Our company, with its commitment to quality and extensive expertise in cutting-edge genetic engineering, is dedicated to providing researchers with reliable tools to unlock the mysteries of gene biology and its clinical implications.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.